ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
0,00%
Dow Jones
38 589,16
-0,15%
DAX
18 020,49
0,00%
Brent Oil
81,805
-0,39%
Bitcoin
66 082,71
-0,84%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ARYA Sciences Acquisition Corporation II (ARYBU)

  7. ARYA Sciences Acquisition Corporation II (ARYBU) Actualités

ARYBU

ARYA Sciences Acquisitio... (ARYBU)

ARYA Sciences Acquisition Corporation II
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARYBU
DateHeureSourceTitreSymboleSociété
29/06/202301h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
15/06/202322h37Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
14/06/202322h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/05/202301h04Edgar (US Regulatory)Amended Report of Proposed Sale of Securities (144/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
03/05/202322h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202322h46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202322h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
25/04/202319h38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/04/202323h24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
14/02/202323h53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/02/202316h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
09/01/202314h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/11/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
12/08/202212h15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/05/202213h05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/04/202222h18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
01/03/202223h45Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
01/03/202222h41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/11/202113h30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/11/202112h54Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
30/08/202122h25Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
10/08/202116h34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
02/07/202123h23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
25/11/202022h19Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
16/11/202022h52Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
28/10/202012h00GlobeNewswire Inc.Cerevel Therapeutics Debuts as Publicly Traded Neuroscience CompanyNASDAQ:ARYBUARYA Sciences Acquisition Corporation II
27/10/202021h34Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
26/10/202022h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
21/10/202018h34GlobeNewswire Inc.ARYA Sciences Acquisition Corp II Announces Extraordinary General Meeting Teleconference DetailsNASDAQ:ARYBUARYA Sciences Acquisition Corporation II
02/10/202023h20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ARYBUARYA Sciences Acquisition Corporation II
 Showing the most relevant articles for your search:NASDAQ:ARYBU

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
VK
Vallourec
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
EU
EN
Bouygues
USI
USTECH100
US Tech 100
EU
HO
Thales
NYSE
DIS
Walt Disney
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés